學 習 工 作 經 歷 |
學習經歷： 2012/09-2016/06,，沈陽藥科大學,，中藥學院,，中藥學,，博士 2003/09-2006/06,，山西醫(yī)科大學,，藥學院,，藥劑學,，碩士 1998/09-2002/07,，山西醫(yī)科大學,，藥學院，藥學,，學士 工作經歷： 2019-01至現(xiàn)在,，山西醫(yī)科大學,，藥學院，副教授 2019-01至2019-12,，美國賓夕法尼亞州,，匹茲堡大學，藥學院,，訪問學者 2010-01至2018-12,，山西醫(yī)科大學，藥學院,，講師 2007-06至2009-12,，山西醫(yī)科大學，藥學院,，助教 |
代表性 論 文 |
1. Wenju Guo?, Ning Li?, Guolian Ren*, RongRong Wang, Liqin Chai, Yujie Li, Xi Wang, Shuai Duan, Jiaqi Tang, Qingshan Yang, Guoshun Zhang, Xiaoqing Shang, Hengtong Zuo, Bofang Yi, Yuwei Wang and Shuqiu Zhang*. Pharmacokinetics and antimalarial pharmacodynamics of dihydroartemisinin trimer self-assembled nanoparticles in murine. Parasitology Research, 2021, 120 (8), 2827-2837. 2. Rongrong Wang, Guolian Ren*, Liqing Chai, Wenju Guo, Yujie Li, Ruili Wang, Yongdan Zhao, Shuqiu Zhang*. Pharmacokinetics and antimalarial activities of reduction-responsive releasing dihydroartemisinin prodrug self-assembled nanoparticles in rodents. Journal of Drug Delivery Science and Technology, 2021, 63, 102515. 3. Ruili Wang#, Guangyu Shi#, Liqing Chai, Rongrong Wang, Guoshun Zhang, Guolian Ren*, Shuqiu Zhang*. Choline and PEG dually modified artemether nano delivery system targeting intra-erythrocytic plasmodium and its pharmacodynamics in vivo. Drug Development and Industrial Pharmacy, 2021, 47 (3): 454-464. 4. Guolian Ren, Pei Chen, Jiaqi Tang, Wenju Guo, Rongrong Wang, Ning Li, Yujie Li, Guoshun Zhang, Ruili Wang and Shuqiu Zhang*. In vivo and in vitro evaluation of dihydroartemisinin prodrug nanocomplexes as a nano-drug delivery system: characterization, pharmacokinetics and pharmacodynamics. RSC advances, 2020, 10, 17270-17279. 5. Ning Li?, Wenju Guo?, Yujie Li, Hengtong Zuo, Huihui Zhang, Zhaoyun Wang, Yongdan Zhao, Fan Yang, Guolian Ren* and Shuqiu Zhang*. Construction and Anti-Tumor Activities of Disulfide-Linked Docetaxel-Dihydroartemisinin Nanoconjugates. Colloids and Surfaces B: Biointerfaces, 2020, 191,111018. 6. Shuai Duan, Ruili Wang, Rongrong Wang, Jiaqi Tang, Xiaoyang Xiao, Ning Li, Wenju Guo, Qingshan Yang, Guolian Ren* and Shuqiu Zhang*. In vivo antimalarial activity and pharmacokinetics of artelinic acid-choline derivative liposomes in rodents. Parasitology, 2020, 147(1):58-64. 7. Guolian Ren, Pei Chen, Jiaqi Tang, Rongrong Wang, Shuai Duan, Ruili Wang, Yin Xie*, and Shuqiu Zhang*. Construction and cellular uptake evaluation of redox-responsitive docetaxel prodrug self-assembled nanoparticles. Drug Development and Industrial Pharmacy, 2018, 44(4):598-607. 8. Guolian Ren, Mengjuan Jiang, Weiling Guo, Bingjun Sun, He Lian, Yongjun Wang and Zhonggui He. Construction and cellular uptake behavior of redox-sensitive docetaxel prodrug-loaded liposomes. Pharmaceutical Development and Technology, 2018, 23(1):22-32. 9. Guolian Ren, Mengjuan Jiang, Peng Xue, Jing Wang, Yongjun Wang, Bo Chen, Zhonggui He. A unique highly hydrophobic anticancer prodrug self-assembled nanomedicine for cancer therapy. Nanomedicine: Nanotechnology, Biology, and Medicine, 2016,12(8):2273-2282. 10. GuoLian Ren, Dan Liu, Weiling Guo, Menglin Wang, Chunnuan Wu, Mengran Guo, Xiaoyu Ai, Yongjun Wang, Zhonggui He. Docetaxel prodrug liposomes for tumor therapy: characterization, in vitro and in vivo evaluation. Drug Delivery, 2016, 23 (4): 1272-1281. |
